FINASTERIDE, MSD - INNOVATION IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA - SUMMARY AND CONCLUSIONS

被引：0
|
作者：
ALTWEIN, JE
机构：
来源：
EUROPEAN UROLOGY | 1993年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [21] Specialists disagree on finasteride use in benign prostatic hyperplasia
    Pirisi, A
    LANCET, 1998, 351 (9104): : 730 - 730
  • [22] Finasteride to prevent morbidity from benign prostatic hyperplasia
    Wasson, JH
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (09): : 612 - 613
  • [23] The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
    Lepor, H
    Williford, WO
    Barry, MJ
    Brawer, MK
    Dixon, CM
    Gormley, G
    Haakenson, C
    Machi, M
    Narayan, P
    Padley, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (08): : 533 - 539
  • [24] Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (05) : 1209 - 1211
  • [25] Effects of finasteride on prostatic blood flow in patients with benign prostatic hyperplasia
    Frauscher, F
    Klauser, A
    Furthmueller, B
    Feuchtner, G
    Pingerra, G
    Horninger, W
    Bartsch, G
    JOURNAL OF UROLOGY, 2003, 169 (04): : 476 - 476
  • [26] The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary)
    Sabnis, Ravindra
    Mulawkar, Prashant
    Joshi, Rohit
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (03) : 210 - 213
  • [27] FINASTERIDE FOR THE TREATMENT AND CONTROL OF BENIGN PROSTATIC HYPERPLASIA - SUMMARY OF PHASE-III CONTROLLED-STUDIES
    GRINO, P
    STONER, E
    EUROPEAN UROLOGY, 1993, 25 : 24 - 28
  • [28] Patient satisfaction with finasteride in the treatment of symptomatic benign prostatic hyperplasia
    Kaplan, SA
    Olsson, CA
    CLINICAL THERAPEUTICS, 1996, 18 (01) : 73 - 83
  • [29] FINASTERIDE (MK-906) IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    MOCELLINI, AI
    GARDINER, R
    MARSHALL, V
    JOHNSON, W
    BARTSCH, G
    SCHMIDBAUER, CP
    MOSSING, H
    VANCANGH, PJ
    DENIS, LJ
    ARAP, S
    FREIRE, GC
    DELATORRE, D
    BOTTO, H
    RICHARD, F
    DEVONEE, M
    TEILLAC, P
    VALLANCIEN, G
    BRAF, Z
    DISILVERIO, F
    MIANO, L
    PAGANO, F
    GABILONDO, F
    DEBRUYNE, F
    JANKNEGT, RA
    SCHROEDER, FH
    NACEY, J
    FURTADO, LA
    CARRETERO, P
    JIMENEZ, FC
    HAURI, D
    OTTO, U
    ALBRECHT, J
    ALTWEIN, JE
    EGGHART, G
    ENGELMANN, U
    JACOBI, GH
    KREYES, G
    PANIJEL, M
    RIEDASCH, G
    RUGENDORFF, EW
    FABRICIUS, P
    OBOYLE, PJ
    GINGELL, C
    BUCK, AC
    CHARIG, C
    GRINO, P
    FERGUSON, D
    ROUND, E
    SHIH, J
    STONER, E
    PROSTATE, 1993, 22 (04): : 291 - 299
  • [30] Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia
    Magoha, GAO
    EAST AFRICAN MEDICAL JOURNAL, 1998, 75 (05) : 260 - 263
12345